Matthew Glaser, Turner’s chief of investment strategies and executive managing director, is the manager of the market neutral fund, which will invest across all major market segments.
Vijay Shankaran, a senior portfolio manager who is also a medical doctor, is manager of the medical sciences fund, which will invest in healthcare companies of all market capitalizations.
And Christopher Baggini, also a senior portfolio manager, is running the Titan fund, which will invest in large-cap stocks.
With these offerings, Turner now has four alternative funds, the fourth being the Turner Spectrum Fund, which is a multi-manager fund consisting of eight Turner long/short investment strategies.
